Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Zydus Cadila secures USFDA nod to market acne drug
The dug will be produced at the group’s Topical manufacturing facility at Ahmedabad in Gujarat, India. This combination medication, according to the pharma company, is used to treat
The dug will be produced at the group’s Topical manufacturing facility at Ahmedabad in Gujarat, India. This combination medication, according to the pharma company, is used to treat
The vaccine, called Vaxelis, is indicated to prevent diphtheria, tetanus, poliomyelitis, pertussis, hepatitis B and invasive disease due to Haemophilus influenzae type b. It has been approved for
ACO is commonly associated with the ingestion of ‘edibles’ such as brownies, cookies and candies that contain large quantities of D9-tetrahydrocannabinol (THC) and synthetic cannabinoids that are more
The FDA will review the NDA for KPI-121 0.25%, which is designed to provide temporary relief to the signs and symptoms of dry eye disease, including dry eye
PCOS is the most common endocrine disorder found in reproductive-age women, and is a major cause of infertility and type 2 diabetes. The source of the disease is
Scars caused by eye infection or trauma convert the usually transparent cornea into an opaque state, thereby leading to blurred vision or complete blindness. Compared with existing standard
Indian pharmaceutical company Lupin has awarded the licensing rights of its Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 (MALT1) programme to AbbVie. The deal gives AbbVie exclusive global
PNH is a rare and acquired blood disease that results in the rupture or destruction of red blood cells (hemolysis). People diagnosed with PNH lack a certain protein